Higher LVEF in stable heart failure patients was associated with decreased mortality up to 45% (LVEF ≤15% vs 36-45%: HR 1.77; 95% CI 1.48-2.11), but increases above 45% showed no further reductions.
Observational (n=7,788)
In stable heart failure patients, mortality risk decreases linearly as LVEF increases up to 45%, but plateaus at higher ejection fractions.
Effect estimate: HR 1.77 (95% CI 1.48 to 2.11)
Absolute Event Rate: 51.7% vs 25.6%
p-value: p=< 0.0001
OBJECTIVES: The aim of this study was to assess the prognostic importance of left ventricular ejection fraction (LVEF) in stable outpatients with heart failure (HF). BACKGROUND: Although LVEF is an accepted prognostic indicator of prognosis in HF patients, the relationship of LVEF and mortality across the full spectrum of LVEF is incompletely understood. METHODS: We examined the association of LVEF and outcomes among 7,788 stable HF patients enrolled in the Digitalis Investigation Group trial. RESULTS: During mean follow-up of 37 months, mortality was substantial in all LVEF groups (range, LVEF 55%, 23.5%). Among patients with LVEF 45% both before (LVEF 46% to 55%: 23.3%; LVEF > 55%: 23.5%; p = 0.25), and after multivariable adjustment (LVEF 46% to 55%: HR 0.92, 95% CI 0.77 to 1.10; LVEF > 55%: HR 0.88, 95% CI 0.71 to 1.09; LVEF 36% to 45%: referent). Patients with lower LVEF were at increased absolute risk of death due to arrhythmia and worsening HF, but these were leading causes of death in all LVEF groups. CONCLUSIONS: Among HF patients in sinus rhythm, higher LVEFs were associated with a linear decrease in mortality up to an LVEF of 45%. However, increases above 45% were not associated with further reductions in mortality.
Curtis et al. (Fri,) conducted a observational in stable outpatients with heart failure (n=7,788). Left ventricular ejection fraction (LVEF) ≤ 15% vs. LVEF 36% to 45% was evaluated on mortality (HR 1.77, 95% CI 1.48 to 2.11, p=< 0.0001). Higher LVEF in stable heart failure patients was associated with decreased mortality up to 45% (LVEF ≤15% vs 36-45%: HR 1.77; 95% CI 1.48-2.11), but increases above 45% showed no further reductions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: